ICI Bulletin

Interview Dario Neri: "Ligand-based pharmacodelivery is a simple, powerful concept"

Interview Niels Eijkelkamp: "Off-switch for chronic pain may reside in the immune system"

Interview Benedikt Kessler: "The ubiquitin field has diversified amazingly"

Interview Jolanda de Vries: "Key to vaccines lies in the tumor microenvironment"

Interview Matthew Bogyo: "Probing the secrets of proteases"

Interview Karin de Visser: "Current immunotherapies are only the tip of the iceberg"

Interview Carolyn Bertozzi: "Glyco is the next wave"

Interview Jannie Borst: "It should be useful and fun"

Interview Joost Snijder: "There has to be some kind of pattern"

Interview Sjaak Neefjes: "ICI should not become a closed circuit"

Interview Kim Bonger: "I really enjoy developing new methods"

Interview Piet Gros: "Still plenty of unansweerd questions"

Interview Ton Schumacher: "Twenty years ago, nobody believed in immunotherapy"

Interview Albert Heck: "Addressing old problems using new technologies"

Interview Jet Bussemaker: "Scientific cross-overs provide the research questions for the future"

Interview Martijn Verdoes: "Being at the right place at the right time"

Interview Hermen Overkleeft: "Chemical solutions for biological problems"